Manske Wealth Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$470K Buy
11,028
+216
+2% +$9.65K 0.12% 141
2026
Q1
$521K Buy
10,812
+192
+2% +$8.95K 0.15% 117
2025
Q4
$515K Sell
10,620
-251
-2% -$12.4K 0.15% 112
2025
Q3
$513K Sell
10,871
-157
-1% -$7.58K 0.16% 108
2025
Q2
$533K Hold
11,028
– – 0.18% 106
2025
Q1
$612K Buy
11,028
+387
+4% +$20.9K 0.23% 89
2024
Q4
$513K Buy
+10,641
New +$541K 0.2% 95

Other funds holding SNY

Manske Wealth Management's SNY Position: Q2 2026 in Review

Manske Wealth Management increased its Sanofi (SNY) stake by 2% in Q2 2026, buying an estimated $9.65K and bringing the position to 11,028 shares worth $470K. The position accounts for 0.12% of the portfolio, ranked #141.

Manske Wealth Management first reported a position in SNY in Q4 2024 and has held it in 7 quarters since. The position peaked at $612K in Q1 2025. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Manske Wealth Management held 11,028 shares of Sanofi worth $470K as of Q2 2026.
  • Manske Wealth Management bought 216 Sanofi shares in Q2 2026, an estimated $9.65K.
  • Sanofi made up 0.12% of Manske Wealth Management's portfolio in Q2 2026, its #141 holding.
  • Manske Wealth Management first reported a position in Sanofi in Q4 2024 and has held it in 7 quarters since.
  • Manske Wealth Management's Sanofi position peaked at $612K in Q1 2025.
  • 718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Manske Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.